Effervescent naproxen tablets now available

Stirlescent is the first licensed effervescent formulation of naproxen. It is indicated in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute musculoskeletal disorders, dysmenorrhoea and acute gout in adults.

Further information
View Stirlescent drug record
Summary of Product Characteristics
Manufacturer: Stirling Anglian

The NHS list price of Stirlescent is £7.90 for a pack of 20 blackcurrant-flavoured 250mg tablets.

Stirlescent has been accepted for restricted use within NHS Scotland in patients unable to swallow naproxen tablets.

As with all NSAIDs, the lowest effective dose should be used for the shortest duration necessary to control symptoms.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Topical Steroids, Comparison of Potencies and Formulations

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.